Esketamine is associated with a 7-point reduction in symptoms of treatment-resistant depression at week 1, with nearly 50% of patients responding by week 4, in new research.

For those with treatment-resistant depression, traditional methods often fall short. Learn about TMS, a non-invasive option.

Study of 2,197 patients with resistant depression finds 95 percent improved once parasympathetic and sympathetic ...

Consider a house with the water main half shut. The faucets sputter. The toilet runs all night. The garden wilts. You could call a plumber for the faucet, a landscaper for the garden, a different ...

Trump and Kennedy have a chance to lead on psychedelic medicine, offering hope for veterans and mental health.

Struggling with depression or anxiety can feel overwhelming—and deciding whether to start a medication like Effexor adds ...

Many Australians are taking medicinal cannabis for their anxiety, depression and post-traumatic stress disorder. But does it ...

The San Francisco supervisor is unlikely to meet serious resistance at City Hall if she decides to stay on after her health ...

The Supreme Court's recent decision will enable the overturning of Colorado's ban on conversion therapy for minors.

Watching Selena Gomez navigate her journey with bipolar disorder feels like watching a friend finally find their footing ...

It's the latest in a string of court decisions in which the justices sided with claims of First Amendment discrimination at ...